Litcius/Paper detail

Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B

Maria Elisa Mancuso, Aaron Lubetsky, Brigitte Pan‐Petesch, Toshko Lissitchkov, Azusa Nagao, Wilfried Seifert, Yanyan Li, Elena Santagostino

2020Journal of Thrombosis and Haemostasis44 citationsDOIOpen Access PDF

Topics & Concepts

RegimenMedicineDosingAdverse effectSurgeryInternal medicineHemophilia Treatment and ResearchPlatelet Disorders and Treatments
Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B | Litcius